EXOGLYCAN OF RHODOTORULA-RUBRA (DEMME) LO DDER 1889 AS AN IMMUNOMODULATOR

Rhodexman is exoglycan produced by Rhodotorula rubra 341. It has been shown that growing rhodexman's doses (From 1 to 1000 mcg/mouse) increa se functional activity of B lymphocytes and folling down of that doses (from 1000 to 1 mcg/mouse) decrease function of suppressor T cells (T -s) through one day after injection of this exoglyxan. Activity of B c ells has decreased to initial level and activity of T-s lymphocytes ha s increased with maximum dose through seven days alter injection of rh odexman. Amount of antibody to sheep erythrocytes after injection or e xoglycan has depended from dose of rhodexman and time of its injection in immunised mise.